A role for CCL2 in both tumor progression and immunosurveillance.
about
MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancerDissecting the role of bone marrow stromal cells on bone metastases.Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model.Trial Watch: Peptide-based anticancer vaccines.Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.Anti-CCL2: building a reservoir or opening the floodgates to metastasis?Aspirin Breaks the Crosstalk between 3T3-L1 Adipocytes and 4T1 Breast Cancer Cells by Regulating Cytokine Production.CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in MiceThe Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production.N-methyl-N-nitro-N'-nitrosoguanidine induces the expression of CCR2 in human gastric epithelial cells promoting CCL2-mediated migration.Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bImmunosuppressive parameters in serum of ovarian cancer patients change during the disease course.CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathwayIL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte-Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System.Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.A killer choice for cancer immunotherapy.Cytokine networks that mediate epithelial cell-macrophage crosstalk in the mammary gland: implications for development and cancer.Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines.Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted Therapy.Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21.Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology.A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.Monocyte-Derived Dendritic Cells Are Essential for CD8(+) T Cell Activation and Antitumor Responses After Local Immunotherapy.Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.Radical gastric cancer surgery results in widespread upregulation of pro-tumourigenic intraperitoneal cytokines.CC Chemokine Receptor 2 Promotes Recruitment of Myeloid Cells Associated with Insulin Resistance in Non-Alcoholic Fatty Liver Disease.Nonresolving macrophage-mediated inflammation in malignancy.Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients.Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-κB pathway
P2860
Q26849525-ABA2D8C8-B529-4424-B0C1-3F4E886D6AA1Q33904588-D25BC25E-3B86-4D4A-AC68-FB2E654FC72FQ34028872-A05CCCBA-E2CD-49BD-882F-1496E4E07720Q34101036-E37DF588-0BBD-450A-B727-BF2BB0BC22BCQ34458331-72E75421-E290-49B2-B041-4950C02525E2Q34483345-1A14C603-2E43-46A3-AC45-6E33F2378786Q35111874-CD321FF7-885D-4CB1-805A-BD94809C12C1Q35627081-645281CB-C7EB-41BD-9865-5AA00D13F67CQ35900009-B889BEED-60A8-4F98-B91E-4B05D59CFDA9Q36184349-88841CA1-27CC-48EF-9583-2ADBAD24B5BFQ36265616-308994A5-5E12-4989-BC7B-B1AA829CC313Q36275415-B100062D-1A24-4CA3-845D-BB2D2A95453CQ36520272-8C5D2485-CB8F-4988-8567-A681EF323F63Q36782461-E919CF12-BC58-4ABA-AB95-DC732B66D06EQ36821077-B526DB1F-4B7B-4B25-B440-8D9ABAF13E82Q37085840-1439C371-72B4-437A-8250-8B7820CD492BQ37685419-5EF326F7-2390-42E0-B5BE-C4B09E1242E5Q37732220-09013FA1-B918-41AE-8A8B-6BF69DA6CBC0Q38208944-63C2A492-A811-4B18-9C62-485D0628A8B4Q38219828-D7E3DDFA-0639-4CDD-9154-FE997E8B74F4Q38338635-4E58157B-25BD-40EC-86B9-EE304662C5FEQ38842141-395ED8A5-F1CA-43F1-8BD8-D4F94BAE1D37Q38983644-12F44B41-1B3E-41EF-BB69-F39A7E0517E4Q39729731-F3DF81AF-1504-4139-9672-D65E356FEE3EQ41091865-5827C7B5-85F7-4E02-8A39-D78344AAE038Q41338881-A0B01FDA-E755-4D98-8E5E-BE4EB468BA1EQ41585891-B35C6A0A-4F2C-47C8-8CEA-1F1967343462Q42740331-A5CB775D-BA4E-4867-BE0D-461B8B377B4DQ46026383-558ED94E-6EFF-4184-BE4E-0700C7ECDA7EQ47275348-C716717A-8F54-4A35-B62B-861B0E9D4BBAQ47384181-D30C8641-585E-4ECA-AF3E-168459D786ACQ50116449-62D159E0-A0B7-4493-BF6F-52FC5D0FB742Q50249667-98B11FA3-B714-420F-856B-6FA81A9390B0Q55093340-9B55CDF1-8EE7-4F86-9B11-A1EF9AC69FE7Q58582578-57E9F654-2A33-47C9-B1B7-64FF2615BE41
P2860
A role for CCL2 in both tumor progression and immunosurveillance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role for CCL2 in both tumor progression and immunosurveillance.
@en
A role for CCL2 in both tumor progression and immunosurveillance.
@nl
type
label
A role for CCL2 in both tumor progression and immunosurveillance.
@en
A role for CCL2 in both tumor progression and immunosurveillance.
@nl
prefLabel
A role for CCL2 in both tumor progression and immunosurveillance.
@en
A role for CCL2 in both tumor progression and immunosurveillance.
@nl
P2093
P2860
P356
P1433
P1476
A role for CCL2 in both tumor progression and immunosurveillance.
@en
P2093
Deborah A Knight
Linda A Snyder
Trina J Stewart
P2860
P304
P356
10.4161/ONCI.25474
P577
2013-07-01T00:00:00Z